DeepMed Research

NATIONWIDE CHILDREN'S HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1892-01-01

Employees: 10K

Market Cap: -

Website: http://www.nationwidechildrens.org

Clinical Trials

Safety and Efficacy of Expanded, Universal Donor Natural Killer Cells for Relapsed/Refractory AML

Phase 1

Recruiting

Conditions: Acute Myeloid Leukemia

Interventions: Biological: Universal Donor Natural Killer Cells

First Posted Date: 2022-08-16

Last Posted Date: 2024-11-04

Lead Sponsor: Nationwide Children's Hospital

Target Recruit Count: 20

Registration Number: NCT05503134

Locations: 🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States

Evaluation of a Novel Intervention to Prevent Polysubstance Overdoses Involving Illicit Stimulants

Not Applicable

Recruiting

Conditions: Harm Reduction
Opiate Overdose
Fentanyl Overdose

Interventions: Behavioral: Fentanyl Test Strips

First Posted Date: 2022-08-09

Last Posted Date: 2024-04-16

Lead Sponsor: Nationwide Children's Hospital

Target Recruit Count: 1750

Registration Number: NCT05493475

Locations: 🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States

Evaluating an Intervention to Prevent Overdoses in Rural and Urban Counties

Not Applicable

Active, not recruiting

Conditions: Harm Reduction
Opiate Overdose
Fentanyl Overdose

Interventions: Behavioral: Fentanyl Test Strips

First Posted Date: 2022-07-19

Last Posted Date: 2025-01-28

Lead Sponsor: Nationwide Children's Hospital

Target Recruit Count: 2400

Registration Number: NCT05463341

Locations: 🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States

Survey to Identify Substance Use in Teenagers and Adolescents

Conditions: Anesthesia

Interventions: Other: Survey

First Posted Date: 2022-04-29

Last Posted Date: 2022-07-01

Lead Sponsor: Nationwide Children's Hospital

Target Recruit Count: 1000

Registration Number: NCT05353036

Locations: 🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States

Parental Perceptions on Prescription Opioid Use

Completed

Conditions: Orthopedic Disorder

Interventions: Other: Survey

First Posted Date: 2022-04-25

Last Posted Date: 2024-06-28

Lead Sponsor: Nationwide Children's Hospital

Target Recruit Count: 125

Registration Number: NCT05344118

Locations: 🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States

MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Phase 2

Recruiting

Conditions: Adamantinous Craniopharyngioma
Recurrent Adamantinomatous Craniopharyngioma

Interventions: Drug: Binimetinib Oral Tablet [Mektovi]

First Posted Date: 2022-03-18

Last Posted Date: 2025-04-01

Lead Sponsor: Nationwide Children's Hospital

Target Recruit Count: 38

Registration Number: NCT05286788

Locations: 🇨🇦
British Columbia Children's Hospital, Vancouver, British Columbia, Canada
🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States
🇺🇸
Children's National Medical Center, Washington DC, District of Columbia, United States

and more 6 locations

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Phase 1

Recruiting

Conditions: Recurrent Diffuse Intrinsic Pontine Glioma
High Grade Glioma
Meningioma
Recurrent Malignant Glioma
Refractory Malignant Glioma
Refractory Primary Central Nervous System Neoplasm
Embryonal Tumor
Recurrent Medulloblastoma
Refractory Diffuse Intrinsic Pontine Glioma
Recurrent Primary Central Nervous System Neoplasm

Interventions: Drug: LUTATHERA® (Lutetium Lu 177 dotatate)

First Posted Date: 2022-03-14

Last Posted Date: 2025-02-17

Lead Sponsor: Nationwide Children's Hospital

Target Recruit Count: 65

Registration Number: NCT05278208

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States
🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States

and more 1 locations

GM-CSF for Reversal of Immunoparalysis in Pediatric Sepsis-induced MODS

Phase 3

Terminated

Conditions: Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome

Interventions: Other: Placebo
Drug: GM-CSF

First Posted Date: 2022-03-04

Last Posted Date: 2024-12-18

Lead Sponsor: Nationwide Children's Hospital

Target Recruit Count: 141

Registration Number: NCT05266001

Locations: 🇺🇸
Arkansas Children's Hospital, Little Rock, Arkansas, United States
🇺🇸
Children's Hospital of Los Angeles, Los Angeles, California, United States
🇺🇸
Benioff Children's Hospital - Oakland, Oakland, California, United States

and more 22 locations

Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS

Phase 2

Recruiting

Conditions: Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS)

Interventions: Drug: Placebo
Drug: Anakinra

First Posted Date: 2022-03-04

Last Posted Date: 2024-12-18

Lead Sponsor: Nationwide Children's Hospital

Target Recruit Count: 500

Registration Number: NCT05267821

Locations: 🇺🇸
University of California, Davis, Sacremento, California, United States
🇺🇸
Riley Children's Hospital, Indianapolis, Indiana, United States
🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

and more 24 locations

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Phase 2

Recruiting

Conditions: Adamantinomatous Craniopharyngioma
Recurrent Adamantinomatous Craniopharyngioma

Interventions: Drug: Tocilizumab

First Posted Date: 2022-02-10

Last Posted Date: 2025-04-17

Lead Sponsor: Nationwide Children's Hospital

Target Recruit Count: 38

Registration Number: NCT05233397

Locations: 🇺🇸
Children's National Medical Center, Washington, District of Columbia, United States
🇺🇸
Seattle Children's Hospital, Seattle, Washington, United States
🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

and more 7 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy